Zdrowie i gospodarka · 21/06/2007
FDA Announces Availability of Revised Draft Guidance on Pharmacovigilance of Veterinary Medicinal Products
The FDA is seeking public comments on a revised draft guidance for the pharmaceutical industry on pharmacovigilance of veterinary medicinal products, which outlines the data elements for reporting adverse events.
Source: Federal Register — Food and Drug AdministrationOpen original release →